Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-08-13
2009-12-22
Kosar, Andrew D (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C514S003100, C530S300000, C530S345000, C424S400000, C424S407000, C424S408000, C424S409000, C424S417000, C424S420000, C424S470000
Reexamination Certificate
active
07635675
ABSTRACT:
Fatty acid salt particles having a size distribution wherein the particles are from about 1 to about 1,000 microns in diameter, use of the particles in pharmaceutical compositions, as well as methods of making and using the particles and compositions.
REFERENCES:
patent: 3957662 (1976-05-01), Sangekar et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4310543 (1982-01-01), Gallo-Torres
patent: 4439420 (1984-03-01), Mattei et al.
patent: 4704284 (1987-11-01), Beatty
patent: 4886669 (1989-12-01), Ventouras
patent: 4900734 (1990-02-01), Maxson
patent: 5028432 (1991-07-01), Chopra
patent: 5140021 (1992-08-01), Maxson
patent: 5147655 (1992-09-01), Ibsen
patent: 5359030 (1994-10-01), Ekwuribe
patent: 5405877 (1995-04-01), Greenwald
patent: 5428128 (1995-06-01), Mensi-Fattohi et al.
patent: 5518998 (1996-05-01), Backstrom et al.
patent: 5532002 (1996-07-01), Story
patent: 5536508 (1996-07-01), Canal et al.
patent: 5567422 (1996-10-01), Greenwald
patent: 5589455 (1996-12-01), Woo
patent: 5612460 (1997-03-01), Zalipsky
patent: 5637749 (1997-06-01), Greenwald
patent: 5681811 (1997-10-01), Ekwuribe
patent: 5736542 (1998-04-01), Henry
patent: 5900402 (1999-05-01), Shorr
patent: 5929030 (1999-07-01), Hamied
patent: 5985263 (1999-11-01), Lee
patent: 6057139 (2000-05-01), Kulkarni et al.
patent: 6113906 (2000-09-01), Greenwald
patent: 6200602 (2001-03-01), Watts
patent: 6214330 (2001-04-01), Greenwald
patent: 6251427 (2001-06-01), Kim
patent: 6303569 (2001-10-01), Greenwald
patent: 6486124 (2002-11-01), Olbrich
patent: 6610653 (2003-08-01), Backström
patent: 6627219 (2003-09-01), Hao
patent: 6703381 (2004-03-01), Ekwuribe
patent: 6770625 (2004-08-01), Soltero
patent: 6858580 (2005-02-01), Ekwuribe
patent: 6867183 (2005-03-01), Soltero
patent: 2002/0187536 (2002-12-01), Kulkarni et al.
patent: 2003/0050228 (2003-03-01), Ekwuribe et al.
patent: 2003/0069170 (2003-04-01), Soltero et al.
patent: 0230332 (1987-07-01), None
patent: 1331002 (2003-07-01), None
patent: 2391473 (2004-02-01), None
patent: 52156916 (1977-12-01), None
patent: 55153712 (1980-11-01), None
patent: 56131514 (1981-10-01), None
patent: 57064609 (1982-04-01), None
patent: 57064610 (1982-04-01), None
patent: 57158719 (1982-09-01), None
patent: 58013508 (1983-01-01), None
patent: 58206515 (1983-12-01), None
patent: 59051223 (1984-03-01), None
patent: 59148735 (1984-08-01), None
patent: 59175433 (1984-10-01), None
patent: 60146825 (1985-08-01), None
patent: 60214735 (1985-10-01), None
patent: 60218318 (1985-11-01), None
patent: 61012632 (1986-01-01), None
patent: 61076416 (1986-04-01), None
patent: 61233625 (1986-10-01), None
patent: 62252723 (1987-11-01), None
patent: 63017821 (1988-01-01), None
patent: 1019018 (1989-01-01), None
patent: 1224315 (1989-09-01), None
patent: 2004712 (1990-01-01), None
patent: 2223526 (1990-09-01), None
patent: 3128322 (1991-05-01), None
patent: 3200715 (1991-09-01), None
patent: 3251536 (1991-11-01), None
patent: 7215883 (1995-08-01), None
patent: 8003074 (1996-01-01), None
patent: 10001436 (1998-01-01), None
patent: 10045629 (1998-02-01), None
patent: 2000095676 (2000-04-01), None
patent: 2000344661 (2000-12-01), None
patent: 63280017 (2006-11-01), None
patent: WO9004385 (1990-05-01), None
patent: WO9221348 (1992-12-01), None
patent: WO 94/08610 (1994-04-01), None
patent: WO9508983 (1995-04-01), None
patent: WO9908666 (1999-02-01), None
patent: WO9913739 (1999-03-01), None
patent: WO0053212 (2000-09-01), None
patent: WO0059482 (2000-10-01), None
patent: WO0239983 (2002-05-01), None
patent: WO03007920 (2003-01-01), None
patent: WO03017986 (2003-03-01), None
patent: WO2004047871 (2004-06-01), None
patent: WO2004054540 (2004-07-01), None
patent: WO2004073693 (2004-09-01), None
patent: WO2005004919 (2005-01-01), None
patent: WO2005079853 (2005-09-01), None
patent: WO2005089714 (2005-09-01), None
patent: WO2005105050 (2005-11-01), None
patent: WO2005115341 (2005-12-01), None
Sakuma et al. Design of nanoparticles composed of graft copolymers for oral polypeptide delivery. Adv Drug Del Rev., 2001, vol. 47, pp. 21-37.
Motohiro Mishima, et al.; Studies on the Promoting Effects of Medium Chain Fatty Acid Salts on the Nasal Absorption of Insulin in Rats; J.Pharmacobio-Dynamics; 1987; pp. 624-631; vol. 10; No. 11.
Yoshinori Onuki, et al.; Formulation optimization of water-in-oil-water multiple emulsion for intestinal insulin delivery; Journal of Controlled Release; 2004; pp. 91-99; vol. 97, No. 1; Elsevier Science Publishers B.V. Amsterdam, NL.
Florence, A. T. The oral absorption of micro- and nonparticulates: neither exceptional nor unusual. Pharmaceut. Res., 1997, vol. 14, pp. 259-266.
Ermak et al. Uptake and transport of copolymer biodegradable microspheres by rabbit Pyere's patch M cells. Cel Tissue Res., 1995, vol. 279, pp. 433-436.
Opawale Foyeke
Soltero Richard
Biocon Limited
Fuierer Marianne
Kosar Andrew D
Moore & Van Allen PLLC
LandOfFree
Micro-particle fatty acid salt solid dosage formulations for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Micro-particle fatty acid salt solid dosage formulations for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Micro-particle fatty acid salt solid dosage formulations for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4096774